Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-inferiority Comparison of 35 mg Delayed-release Risedronate, Given Once-weekly Either Before or After Breakfast, & 5 mg Immediate-release Risedronate, Given Once-daily Before Breakfast, in the Treatment of Postmenopausal Osteoporosis.

NCT00541658 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.

NCT NCT00541658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00541658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-inferiority Comparison of 35 mg Delayed-release Risedronate, Given Once-weekly Either Before or After Breakfast, & 5 mg Immediate-release Risedronate, Given Once-daily Before Breakfast, in the Treatment of Postmenopausal Osteoporosis.
Lead sponsor
Warner Chilcott
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2007
Completion date
April 30, 2010
Enrollment
923 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis